BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24469042)

  • 41. Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities.
    Gilbert-Dussardier B; Briand-Suleau A; Laurendeau I; Bilan F; Cavé H; Verloes A; Vidaud M; Vidaud D; Pasmant E
    Orphanet J Rare Dis; 2016 Jul; 11(1):101. PubMed ID: 27450488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1.
    Wimmer K; Rosenbaum T; Messiaen L
    Clin Genet; 2017 Apr; 91(4):507-519. PubMed ID: 27779754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
    Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M
    Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pigmentary findings in neurofibromatosis type 1-like syndrome (Legius syndrome): potential diagnostic dilemmas.
    Stevenson D; Viskochil D
    JAMA; 2009 Nov; 302(19):2150-1. PubMed ID: 19920242
    [No Abstract]   [Full Text] [Related]  

  • 45. Choroidal abnormalities in café-au-lait syndromes: a new differential diagnostic tool?
    Cassiman C; Casteels I; Jacob J; Plasschaert E; Brems H; Dubron K; Keer KV; Legius E
    Clin Genet; 2017 Apr; 91(4):529-535. PubMed ID: 27716896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
    Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
    Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Somatic mutation analysis in NF1 café au lait spots reveals two NF1 hits in the melanocytes.
    De Schepper S; Maertens O; Callens T; Naeyaert JM; Lambert J; Messiaen L
    J Invest Dermatol; 2008 Apr; 128(4):1050-3. PubMed ID: 17914445
    [No Abstract]   [Full Text] [Related]  

  • 48. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
    Bernier A; Larbrisseau A; Perreault S
    Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Updated Approach to Patients with Multiple Café au Lait Macules.
    Albaghdadi M; Thibodeau ML; Lara-Corrales I
    Dermatol Clin; 2022 Jan; 40(1):9-23. PubMed ID: 34799039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease.
    Abramowicz A; Gos M
    Dev Period Med; 2014; 18(3):297-306. PubMed ID: 25182393
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011.
    Olsson L; Castor A; Behrendtz M; Biloglav A; Forestier E; Paulsson K; Johansson B
    Leukemia; 2014 Feb; 28(2):302-10. PubMed ID: 23823658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Café au lait spots: When and how to pursue their genetic origins.
    Lalor L; Davies OMT; Basel D; Siegel DH
    Clin Dermatol; 2020; 38(4):421-431. PubMed ID: 32972601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
    Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
    J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SPRED proteins provide a NF-ty link to Ras suppression.
    McClatchey AI; Cichowski K
    Genes Dev; 2012 Jul; 26(14):1515-9. PubMed ID: 22802525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epilepsy in Legius syndrome: Coincidence or causation?
    Medina Lemus A; Boelman C; Myers KA
    Am J Med Genet A; 2024 Jun; 194(6):e63547. PubMed ID: 38268057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous Detection of
    Bianchessi D; Ibba MC; Saletti V; Blasa S; Langella T; Paterra R; Cagnoli GA; Melloni G; Scuvera G; Natacci F; Cesaretti C; Finocchiaro G; Eoli M
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32575496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel mutation in SPRED1: a sporadic case of Legius syndrome in an infant.
    Chen L; Wang Y; Fang H; Liu X; Li Q
    Eur J Dermatol; 2023 Apr; 33(2):168-170. PubMed ID: 37431124
    [No Abstract]   [Full Text] [Related]  

  • 58. The diagnostic and clinical significance of café-au-lait macules.
    Shah KN
    Pediatr Clin North Am; 2010 Oct; 57(5):1131-53. PubMed ID: 20888463
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
    Gottfried ON; Viskochil DH; Couldwell WT
    Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.